Diligence memo · auto-generated · as of July 2, 2026
Acuamark Diagnostics, Inc.
Acuamark Diagnostics, Inc. looks under-valued against its niche peers and is quiet on financing cadence.
Businessfiled
Acuamark Diagnostics, Inc. operates in Medical Devices, based in NEW YORK.
Sub-sector tags: medical-devices.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Acuamark Diagnostics, Inc. has raised $20M in disclosed capital across 4 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $12M on 2022-03-21.
Most recent recorded round closed around 2024-05-22.
Valuation (modeled)modeled
Provath models Acuamark Diagnostics, Inc. at approximately $26M (range $6.1M–$57M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.44× the median modeled value of Series A Medical Devices companies in 2022–2024 (13 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 31 months.
Last raise 2.1 yr ago; this sector typically re-raises about every 16 months.
Slightly overdue versus sector cadence.
The last round was 2.4× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 88% of Medical Devices peers (233 compared).
Modeled value ranks above 66% of those peers.
Closest niche peers: MBio Diagnostics, Inc., Vida Diagnostics Inc, New View Surgical, Inc., Thunder Road Surgical, Llc, Barsa Surgical Inc..
Peoplefiled
13 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.